You are here: Industry Insights > Chief Executive Officer

News List

Executive Moves at Roche contractpharma
December 12, 2018
Daniel O'Day, chief executive officer of Roche Pharmaceuticals and member of the Corporate Executive Committee, will be stepping down from his role as of 31 December 2018.
BlueRock, McEwen Stem Cell Institute Expand Alliance contractpharma
December 10, 2018
BlueRock Therapeutics, an engineered cell therapy company, has expanded its ongoing strategic collaboration with the McEwen Stem Cell Institute at the University Health Network (UHN) in Toronto.
Concordia International Becomes ADVANZ PHARMA contractpharma
December 03, 2018
Concordia International Corp. has changed its name to ADVANZ PHARMA Corp. The resolution was voted for by shareholders, and approximately 99.9 per cent of the votes cast were in favor of the change.
Fette Compacting COO to Depart contractpharma
December 03, 2018
Stefan Moll belonged to the Management Board of Fette Compacting since October 2016. From this date, Stefan Moll assumed responsibility for Production, R&D/Engineering and Processes/Quality.
Oncolytics Biotech Appoints CMO contractpharma
November 30, 2018
Oncolytics Biotech announced that Dr. Rita Laeufle, M.D., Ph.D., who has been working as a consultant for Oncolytics for the last four months, has been appointed as chief medical officer. Dr. Laeufle will oversee the clinical development plan for pelareo
Nkarta Appoints SVP & CMO contractpharma
November 28, 2018
Dr. Rajangam, who will be joining the company in December, is an experienced biotechnology executive with a track record of successfully developing cancer therapies.
Sygnature Discovery Establishes U.S. Ops contractpharma
November 28, 2018
Sygnature Discovery, a drug discovery and preclinical services company, is expanding its operations with the opening of its first U.S. office in Harvard Square, Cambridge, MA.
Piramal Unveils New cGMP Kilo Lab Suite for APIs contractpharma
November 27, 2018
Piramal Pharma Solutions (PPS) has completed its new cGMP kilo lab suite at its active pharmaceutical ingredient (API) site in Ennore, Chennai, India. The suite will formally open on...
ORIC Pharma Appoints CBO firstwordpharma
November 27, 2018
Matt Panuwat has been appointed chief business officer at ORIC Pharmaceuticals, a clinical-stage oncology company focused developing novel therapies against treatment-resistant cancers.
Anchiano Therapeutics Names CMO contractpharma
November 27, 2018
David Kerstein, M.D., has been named chief medical officer of Anchiano Therapeutics, a clinical-stage biopharma company focused on novel therapies to treat cancer.

Previous page 1 2 3 4 Next page